Sudhir Vaid has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudhir Vaid, a person associated with Concord Biotech, has submitted a disclosure to the exchange under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation requires continuing disclosures from those who already hold a significant stake (typically above 5%) in a listed company. The filing confirms compliance with takeover norms, but the specific nature of the disclosure — whether it relates to pledging, buying, selling, or other changes in shareholding — is not detailed in the headline. Retail investors should look for the detailed disclosure document on the company/exchange website for specifics.
This is a routine compliance filing, and on its own does not indicate any material change in the company's control or shareholding structure. Shareholders should check the attached disclosure for any actual change in stake or encumbrance before drawing conclusions about its impact on the stock.